Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-23-004279

Director bought 1,191 shares at $20.98 ($24,987)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Knowles Julius Director 2020-04-13 Purchase +1,191 $20.98 $24,987 1,191 D
Open-market purchases · 1,191 sh · avg $20.98 · $24,987
Loading xslF345X03/doc4.xml…